HEADER OXIDOREDUCTASE 28-APR-00 1EWY TITLE ANABAENA PCC7119 FERREDOXIN:FERREDOXIN-NADP+-REDUCTASE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: FERREDOXIN-NADP REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: 138-440; COMPND 5 EC: 1.18.1.2; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: FERREDOXIN I; COMPND 8 CHAIN: C SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOSTOC SP. PCC 7119; SOURCE 3 ORGANISM_TAXID: 1168; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: NOSTOC SP. PCC 7119; SOURCE 6 ORGANISM_TAXID: 1168 KEYWDS ELECTRON TRANSFER COMPLEX, PHOTOSYNTHESIS, PROTEIN-PROTEIN KEYWDS 2 INTERACTION, FERREDOXIN, REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR R.MORALES,M.H.CHARON,M.FREY REVDAT 3 09-AUG-23 1EWY 1 REMARK REVDAT 2 24-FEB-09 1EWY 1 VERSN REVDAT 1 07-FEB-01 1EWY 0 JRNL AUTH R.MORALES,G.KACHALOVA,F.VELLIEUX,M.H.CHARON,M.FREY JRNL TITL CRYSTALLOGRAPHIC STUDIES OF THE INTERACTION BETWEEN THE JRNL TITL 2 FERREDOXIN-NADP+ REDUCTASE AND FERREDOXIN FROM THE JRNL TITL 3 CYANOBACTERIUM ANABAENA: LOOKING FOR THE ELUSIVE FERREDOXIN JRNL TITL 4 MOLECULE. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 56 1408 2000 JRNL REFN ISSN 0907-4449 JRNL PMID 11053838 JRNL DOI 10.1107/S0907444900010052 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.MORALES,M.H.CHARON,G.KACHALOVA,L.S.SERRE,M.MEDINA, REMARK 1 AUTH 2 C.GOMEZ-MORENO,M.FREY REMARK 1 TITL A REDOX-DEPENDENT INTERACTION BETWEEN TWO ELECTRON-TRANSFER REMARK 1 TITL 2 PARTNERS INVOLVED IN PHOTOSYNTHESIS REMARK 1 REF EMBO J. V. 1 271 2000 REMARK 1 REFN ISSN 0261-4189 REMARK 1 DOI 10.1093/EMBO-REPORTS/KVD057 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.6 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.219 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.232 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2563 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 25701 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.200 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2387 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 21519 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5523 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 110 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 5503.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 22871 REMARK 3 NUMBER OF RESTRAINTS : 23488 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.001 REMARK 3 ANGLE DISTANCES (A) : 0.002 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.033 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.003 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.004 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.019 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.098 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE TWIN OPTION IN SHELX97 WAS USED, WITH REMARK 3 THE TWIN 0 1 0 1 0 0 0 0 -1 2 COMMAND. REMARK 4 REMARK 4 1EWY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAY-00. REMARK 100 THE DEPOSITION ID IS D_1000010979. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25838 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.07700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1QUE FOR FERREDOXIN-NADP+REDUCTASE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 28.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-24% PEG 6000,10 MM MES PH 5.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.86500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.01000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.86000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.01000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.86500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.86000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 THE BIOLOGICAL MOLECULE CONSISTS OF ONE REMARK 300 FERREDOXIN-NADP REDUCTASE AND ONE REMARK 300 FERREDOXIN I. BIOMOLECULE 2 IN REMARK 300 REMARK 350 IS MEANINGLESS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 4 CG CD CE NZ REMARK 470 GLU A 111 CG CD OE1 OE2 REMARK 470 THR A 112 OG1 CG2 REMARK 470 LYS B 4 CG CD CE NZ REMARK 470 GLU B 111 CG CD OE1 OE2 REMARK 470 THR B 112 OG1 CG2 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 THR A 1 REMARK 475 GLN A 2 REMARK 475 ALA A 3 REMARK 475 LYS A 4 REMARK 475 ALA A 5 REMARK 475 LYS A 6 REMARK 475 HIS A 7 REMARK 475 ALA A 8 REMARK 475 ASP A 9 REMARK 475 THR B 1 REMARK 475 GLN B 2 REMARK 475 ALA B 3 REMARK 475 LYS B 4 REMARK 475 ALA B 5 REMARK 475 LYS B 6 REMARK 475 HIS B 7 REMARK 475 ALA B 8 REMARK 475 ASP B 9 REMARK 475 VAL B 10 REMARK 475 PRO B 11 REMARK 475 VAL B 12 REMARK 475 ASN B 13 REMARK 475 ILE B 63 REMARK 475 PRO B 64 REMARK 475 PRO B 65 REMARK 475 GLY B 66 REMARK 475 VAL B 67 REMARK 475 ASP B 68 REMARK 475 LYS B 69 REMARK 475 ASP C 68 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 PHE B 21 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD2 LEU B 14 O ASN B 51 1.72 REMARK 500 CB GLN C 63 CD2 LEU C 66 1.84 REMARK 500 N THR B 1 NE ARG B 16 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 246 CD GLU A 246 OE2 0.077 REMARK 500 GLU B 246 CD GLU B 246 OE2 0.075 REMARK 500 TYR C 98 C TYR C 98 OXT 0.600 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 2 -78.82 -0.60 REMARK 500 LYS A 6 71.11 -169.82 REMARK 500 HIS A 7 136.47 156.72 REMARK 500 ALA A 8 175.37 72.64 REMARK 500 PRO A 11 96.41 -52.68 REMARK 500 ASN A 13 43.27 76.34 REMARK 500 ALA A 19 61.81 -152.76 REMARK 500 ASN A 28 77.39 -169.76 REMARK 500 TYR A 54 172.79 175.23 REMARK 500 ILE A 55 -158.03 -139.52 REMARK 500 LYS A 69 -26.18 -161.30 REMARK 500 GLU A 74 164.31 -48.16 REMARK 500 THR A 84 172.70 -56.96 REMARK 500 ASP A 91 -101.82 -127.27 REMARK 500 ASP A 92 15.53 -175.14 REMARK 500 ILE A 95 143.30 -173.21 REMARK 500 LYS A 138 2.13 -157.88 REMARK 500 ALA A 173 -71.11 -50.43 REMARK 500 GLU A 180 32.10 -85.09 REMARK 500 TYR A 181 76.79 -163.32 REMARK 500 ILE A 199 93.41 -63.70 REMARK 500 GLU A 225 34.19 -156.98 REMARK 500 ASN A 253 177.41 -55.51 REMARK 500 VAL A 283 139.13 -171.90 REMARK 500 ALA B 5 104.19 140.00 REMARK 500 LYS B 6 84.93 169.57 REMARK 500 HIS B 7 135.02 117.87 REMARK 500 ALA B 8 -36.24 102.09 REMARK 500 ASP B 9 -30.91 79.15 REMARK 500 PRO B 20 -135.71 -56.24 REMARK 500 LEU B 47 48.24 -102.23 REMARK 500 PRO B 65 -113.27 -50.52 REMARK 500 VAL B 67 -19.05 164.66 REMARK 500 LYS B 69 -77.08 -163.18 REMARK 500 ASN B 70 68.19 171.12 REMARK 500 LYS B 93 31.16 -140.75 REMARK 500 GLU B 111 171.01 -58.66 REMARK 500 VAL B 116 -70.33 -71.90 REMARK 500 LYS B 138 52.18 -119.67 REMARK 500 PHE B 170 -32.66 -139.32 REMARK 500 ASN B 178 75.80 -119.15 REMARK 500 TYR B 201 30.35 74.63 REMARK 500 LYS B 255 35.09 -96.70 REMARK 500 GLU B 268 -75.35 -51.46 REMARK 500 ALA C 11 -84.16 175.75 REMARK 500 PRO C 21 175.00 -51.91 REMARK 500 ALA C 29 -74.78 -60.86 REMARK 500 SER C 40 -83.18 -153.90 REMARK 500 ALA C 43 28.71 -145.34 REMARK 500 VAL C 54 -76.40 -107.03 REMARK 500 REMARK 500 THIS ENTRY HAS 59 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE C 65 LEU C 66 -138.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FES C 99 FE1 REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS C 41 SG REMARK 620 2 FES C 99 S1 119.6 REMARK 620 3 FES C 99 S2 102.1 102.2 REMARK 620 4 CYS C 46 SG 105.9 108.3 119.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FES C 99 FE2 REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS C 49 SG REMARK 620 2 FES C 99 S1 114.7 REMARK 620 3 FES C 99 S2 111.2 105.6 REMARK 620 4 CYS C 79 SG 104.9 115.6 104.4 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 1304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FES C 99 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QT9 RELATED DB: PDB REMARK 900 1QT9 CONTAINS ANABAENA PCC7119 FERREDOXIN REMARK 900 RELATED ID: 1QUE RELATED DB: PDB REMARK 900 1QUE CONTAINS ANABAENA PCC7119 FERREDOXIN-NADP+-REDUCTASE DBREF 1EWY A 1 303 UNP P21890 FENR_ANASO 138 440 DBREF 1EWY B 1 303 UNP P21890 FENR_ANASO 138 440 DBREF 1EWY C 1 98 UNP P0A3C8 FER1_ANASO 1 98 SEQRES 1 A 303 THR GLN ALA LYS ALA LYS HIS ALA ASP VAL PRO VAL ASN SEQRES 2 A 303 LEU TYR ARG PRO ASN ALA PRO PHE ILE GLY LYS VAL ILE SEQRES 3 A 303 SER ASN GLU PRO LEU VAL LYS GLU GLY GLY ILE GLY ILE SEQRES 4 A 303 VAL GLN HIS ILE LYS PHE ASP LEU THR GLY GLY ASN LEU SEQRES 5 A 303 LYS TYR ILE GLU GLY GLN SER ILE GLY ILE ILE PRO PRO SEQRES 6 A 303 GLY VAL ASP LYS ASN GLY LYS PRO GLU LYS LEU ARG LEU SEQRES 7 A 303 TYR SER ILE ALA SER THR ARG HIS GLY ASP ASP VAL ASP SEQRES 8 A 303 ASP LYS THR ILE SER LEU CYS VAL ARG GLN LEU GLU TYR SEQRES 9 A 303 LYS HIS PRO GLU SER GLY GLU THR VAL TYR GLY VAL CYS SEQRES 10 A 303 SER THR TYR LEU THR HIS ILE GLU PRO GLY SER GLU VAL SEQRES 11 A 303 LYS ILE THR GLY PRO VAL GLY LYS GLU MET LEU LEU PRO SEQRES 12 A 303 ASP ASP PRO GLU ALA ASN VAL ILE MET LEU ALA THR GLY SEQRES 13 A 303 THR GLY ILE ALA PRO MET ARG THR TYR LEU TRP ARG MET SEQRES 14 A 303 PHE LYS ASP ALA GLU ARG ALA ALA ASN PRO GLU TYR GLN SEQRES 15 A 303 PHE LYS GLY PHE SER TRP LEU VAL PHE GLY VAL PRO THR SEQRES 16 A 303 THR PRO ASN ILE LEU TYR LYS GLU GLU LEU GLU GLU ILE SEQRES 17 A 303 GLN GLN LYS TYR PRO ASP ASN PHE ARG LEU THR TYR ALA SEQRES 18 A 303 ILE SER ARG GLU GLN LYS ASN PRO GLN GLY GLY ARG MET SEQRES 19 A 303 TYR ILE GLN ASP ARG VAL ALA GLU HIS ALA ASP GLU LEU SEQRES 20 A 303 TRP GLN LEU ILE LYS ASN GLN LYS THR HIS THR TYR ILE SEQRES 21 A 303 CYS GLY LEU ARG GLY MET GLU GLU GLY ILE ASP ALA ALA SEQRES 22 A 303 LEU SER ALA ALA ALA ALA LYS GLU GLY VAL THR TRP SER SEQRES 23 A 303 ASP TYR GLN LYS ASP LEU LYS LYS ALA GLY ARG TRP HIS SEQRES 24 A 303 VAL GLU THR TYR SEQRES 1 B 303 THR GLN ALA LYS ALA LYS HIS ALA ASP VAL PRO VAL ASN SEQRES 2 B 303 LEU TYR ARG PRO ASN ALA PRO PHE ILE GLY LYS VAL ILE SEQRES 3 B 303 SER ASN GLU PRO LEU VAL LYS GLU GLY GLY ILE GLY ILE SEQRES 4 B 303 VAL GLN HIS ILE LYS PHE ASP LEU THR GLY GLY ASN LEU SEQRES 5 B 303 LYS TYR ILE GLU GLY GLN SER ILE GLY ILE ILE PRO PRO SEQRES 6 B 303 GLY VAL ASP LYS ASN GLY LYS PRO GLU LYS LEU ARG LEU SEQRES 7 B 303 TYR SER ILE ALA SER THR ARG HIS GLY ASP ASP VAL ASP SEQRES 8 B 303 ASP LYS THR ILE SER LEU CYS VAL ARG GLN LEU GLU TYR SEQRES 9 B 303 LYS HIS PRO GLU SER GLY GLU THR VAL TYR GLY VAL CYS SEQRES 10 B 303 SER THR TYR LEU THR HIS ILE GLU PRO GLY SER GLU VAL SEQRES 11 B 303 LYS ILE THR GLY PRO VAL GLY LYS GLU MET LEU LEU PRO SEQRES 12 B 303 ASP ASP PRO GLU ALA ASN VAL ILE MET LEU ALA THR GLY SEQRES 13 B 303 THR GLY ILE ALA PRO MET ARG THR TYR LEU TRP ARG MET SEQRES 14 B 303 PHE LYS ASP ALA GLU ARG ALA ALA ASN PRO GLU TYR GLN SEQRES 15 B 303 PHE LYS GLY PHE SER TRP LEU VAL PHE GLY VAL PRO THR SEQRES 16 B 303 THR PRO ASN ILE LEU TYR LYS GLU GLU LEU GLU GLU ILE SEQRES 17 B 303 GLN GLN LYS TYR PRO ASP ASN PHE ARG LEU THR TYR ALA SEQRES 18 B 303 ILE SER ARG GLU GLN LYS ASN PRO GLN GLY GLY ARG MET SEQRES 19 B 303 TYR ILE GLN ASP ARG VAL ALA GLU HIS ALA ASP GLU LEU SEQRES 20 B 303 TRP GLN LEU ILE LYS ASN GLN LYS THR HIS THR TYR ILE SEQRES 21 B 303 CYS GLY LEU ARG GLY MET GLU GLU GLY ILE ASP ALA ALA SEQRES 22 B 303 LEU SER ALA ALA ALA ALA LYS GLU GLY VAL THR TRP SER SEQRES 23 B 303 ASP TYR GLN LYS ASP LEU LYS LYS ALA GLY ARG TRP HIS SEQRES 24 B 303 VAL GLU THR TYR SEQRES 1 C 98 ALA THR PHE LYS VAL THR LEU ILE ASN GLU ALA GLU GLY SEQRES 2 C 98 THR LYS HIS GLU ILE GLU VAL PRO ASP ASP GLU TYR ILE SEQRES 3 C 98 LEU ASP ALA ALA GLU GLU GLN GLY TYR ASP LEU PRO PHE SEQRES 4 C 98 SER CYS ARG ALA GLY ALA CYS SER THR CYS ALA GLY LYS SEQRES 5 C 98 LEU VAL SER GLY THR VAL ASP GLN SER ASP GLN SER PHE SEQRES 6 C 98 LEU ASP ASP ASP GLN ILE GLU ALA GLY TYR VAL LEU THR SEQRES 7 C 98 CYS VAL ALA TYR PRO THR SER ASP VAL VAL ILE GLN THR SEQRES 8 C 98 HIS LYS GLU GLU ASP LEU TYR HET FAD A 304 53 HET FAD B1304 53 HET FES C 99 4 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM FES FE2/S2 (INORGANIC) CLUSTER FORMUL 4 FAD 2(C27 H33 N9 O15 P2) FORMUL 6 FES FE2 S2 FORMUL 7 HOH *89(H2 O) HELIX 1 1 GLY A 115 HIS A 123 1 9 HELIX 2 2 ILE A 159 LYS A 171 1 13 HELIX 3 3 LYS A 171 ASN A 178 1 8 HELIX 4 4 THR A 195 ILE A 199 5 5 HELIX 5 5 TYR A 201 GLU A 206 1 6 HELIX 6 6 GLU A 206 TYR A 212 1 7 HELIX 7 7 TYR A 235 HIS A 243 1 9 HELIX 8 8 HIS A 243 LYS A 252 1 10 HELIX 9 9 MET A 266 LYS A 280 1 15 HELIX 10 10 THR A 284 LYS A 293 1 10 HELIX 11 11 GLY B 115 HIS B 123 1 9 HELIX 12 12 ILE B 159 ARG B 168 1 10 HELIX 13 13 LYS B 171 ALA B 176 1 6 HELIX 14 14 THR B 195 ILE B 199 5 5 HELIX 15 15 TYR B 201 TYR B 212 1 12 HELIX 16 16 TYR B 235 HIS B 243 1 9 HELIX 17 17 HIS B 243 ASN B 253 1 11 HELIX 18 18 GLY B 265 ALA B 279 1 15 HELIX 19 19 THR B 284 GLY B 296 1 13 HELIX 20 20 TYR C 25 GLU C 32 1 8 HELIX 21 21 ASP C 67 GLU C 72 1 6 HELIX 22 22 CYS C 79 ALA C 81 5 3 SHEET 1 A 3 LYS A 24 PRO A 30 0 SHEET 2 A 3 VAL A 40 ASP A 46 -1 N HIS A 42 O GLU A 29 SHEET 3 A 3 THR A 94 ARG A 100 -1 O ILE A 95 N PHE A 45 SHEET 1 B 3 ARG A 77 SER A 80 0 SHEET 2 B 3 SER A 59 ILE A 63 -1 N ILE A 60 O TYR A 79 SHEET 3 B 3 LYS A 131 PRO A 135 -1 O LYS A 131 N ILE A 63 SHEET 1 C 2 GLU A 103 LYS A 105 0 SHEET 2 C 2 THR A 112 TYR A 114 -1 N VAL A 113 O TYR A 104 SHEET 1 D 5 PHE A 216 ILE A 222 0 SHEET 2 D 5 SER A 187 VAL A 193 1 O SER A 187 N ARG A 217 SHEET 3 D 5 ASN A 149 THR A 155 1 O VAL A 150 N TRP A 188 SHEET 4 D 5 THR A 256 GLY A 262 1 O HIS A 257 N ILE A 151 SHEET 5 D 5 TRP A 298 THR A 302 1 O HIS A 299 N ILE A 260 SHEET 1 E 2 LYS A 227 ASN A 228 0 SHEET 2 E 2 GLY A 232 ARG A 233 -1 O GLY A 232 N ASN A 228 SHEET 1 F 4 THR B 94 ARG B 100 0 SHEET 2 F 4 VAL B 40 ASP B 46 -1 N GLN B 41 O VAL B 99 SHEET 3 F 4 GLY B 23 VAL B 25 -1 O LYS B 24 N ASP B 46 SHEET 4 F 4 GLU B 129 VAL B 130 -1 N VAL B 130 O GLY B 23 SHEET 1 G 3 THR B 94 ARG B 100 0 SHEET 2 G 3 VAL B 40 ASP B 46 -1 N GLN B 41 O VAL B 99 SHEET 3 G 3 GLU B 29 PRO B 30 -1 O GLU B 29 N HIS B 42 SHEET 1 H 2 SER B 59 ILE B 62 0 SHEET 2 H 2 ARG B 77 SER B 80 -1 N ARG B 77 O ILE B 62 SHEET 1 I 2 GLU B 103 LYS B 105 0 SHEET 2 I 2 THR B 112 TYR B 114 -1 N VAL B 113 O TYR B 104 SHEET 1 J 5 PHE B 216 ILE B 222 0 SHEET 2 J 5 SER B 187 VAL B 193 1 O SER B 187 N ARG B 217 SHEET 3 J 5 ASN B 149 THR B 155 1 O VAL B 150 N TRP B 188 SHEET 4 J 5 THR B 256 GLY B 262 1 O HIS B 257 N ILE B 151 SHEET 5 J 5 TRP B 298 THR B 302 1 O HIS B 299 N ILE B 260 SHEET 1 K 5 THR C 14 PRO C 21 0 SHEET 2 K 5 THR C 2 ASN C 9 -1 O PHE C 3 N VAL C 20 SHEET 3 K 5 ILE C 89 GLN C 90 1 O ILE C 89 N ILE C 8 SHEET 4 K 5 ALA C 50 LEU C 53 -1 N LYS C 52 O GLN C 90 SHEET 5 K 5 TYR C 75 LEU C 77 -1 N VAL C 76 O GLY C 51 SHEET 1 L 2 VAL C 58 ASP C 59 0 SHEET 2 L 2 TYR C 82 PRO C 83 -1 N TYR C 82 O ASP C 59 LINK SG CYS C 41 FE1 FES C 99 1555 1555 2.34 LINK SG CYS C 46 FE1 FES C 99 1555 1555 2.28 LINK SG CYS C 49 FE2 FES C 99 1555 1555 2.11 LINK SG CYS C 79 FE2 FES C 99 1555 1555 2.29 SITE 1 AC1 22 ARG A 77 LEU A 78 TYR A 79 SER A 80 SITE 2 AC1 22 CYS A 98 VAL A 99 ARG A 100 LEU A 102 SITE 3 AC1 22 TYR A 104 PRO A 107 GLY A 115 VAL A 116 SITE 4 AC1 22 CYS A 117 SER A 118 THR A 157 GLU A 301 SITE 5 AC1 22 TYR A 303 HOH A 315 HOH A 316 FAD B1304 SITE 6 AC1 22 ALA C 45 SER C 64 SITE 1 AC2 19 FAD A 304 ARG B 77 LEU B 78 TYR B 79 SITE 2 AC2 19 SER B 80 CYS B 98 VAL B 99 ARG B 100 SITE 3 AC2 19 LEU B 102 TYR B 104 GLY B 115 VAL B 116 SITE 4 AC2 19 CYS B 117 SER B 118 THR B 157 GLU B 301 SITE 5 AC2 19 TYR B 303 HOH B1319 HOH B1329 SITE 1 AC3 9 SER C 40 CYS C 41 ARG C 42 GLY C 44 SITE 2 AC3 9 ALA C 45 CYS C 46 CYS C 49 LEU C 77 SITE 3 AC3 9 CYS C 79 CRYST1 63.730 63.720 158.020 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015691 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015694 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006328 0.00000